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It is not clear whether the development of tics can be prevented, but individuals with tics may
be able to use various strategies to prevent the worsening of tics.
Teaching families to shift attention to behaviors that reduce tics instead of attending to tics is
an important part of decreasing tic severity.
Various medications can serve as treatment options to reduce tic severity.
Behavioral treatment is the gold standard psychotherapy intervention for tic disorders, with
multiple studies demonstrating its efficacy and few side effects.
CBIT is the most well-supported nonpharmacological treatment for children with tics.

Introduction

Tourette disorder (TD) is a childhood-onset neurologic condition, which involves the performance of
sudden, repetitive, nonrhythmic motor movements and vocalizations that persist for at least 1 year.1
The disorder is more prevalent in males, and cross-cultural studies suggest that it occurs in about 0.5%
to 1% of youth.2, 3, 4, 5 The condition is believed to result from failed inhibition within cortico-striatalthalamo-cortical circuits, because abnormally active striatal neurons in the basal ganglia lead to the
release of unwanted motor movements and vocalizations.6
Although tic disorders have a neurologic basis, studies demonstrate that the environmental context
plays a significant role in tic expression. Contextual factors, such as particular settings, participating in
activities, reactions of other people to tics, and emotions have all been found to impact tic severity.7
These variables interact with biological processes to help explain the variability in tics. Typical tic onset
occurs between the ages 5 and 7 years, and tics tend to increase in frequency and intensity until
children are approximately 10 to 11 years.2,8, 9, 10 Tics are categorized into simple and complex, motor
and vocal movements. Most tics are simple movements or vocalizations, such as eye blinks, head jerks,
throat clears, or grunts; however, other tics involve coordinated actions by multiple muscle groups.
Examples of complex tics can include fixed sequences of simple tics, touching and tapping, and various
vocalizations.
Premonitory urges, uncomfortable physical sensations, such as an itch or a burn, often precede tics.11
Such experiences are reported by over 90% of individuals with tics, and children often experience but
cannot reliably report urges until approximately age 10 years.12 Premonitory urges may occur in
specific regions of the body where the tic occurs, or they may be experienced as “generalized” across
the entire body. The uncomfortable sensation is usually relieved by the completion of the tic, and
some individuals describe the urge to be more bothersome than the actual tic.13
Children and adolescents seeking treatment of TD usually have mild to moderate tic severity and
impairment related to tics.13,14 Tic severity is greatest around age 10 years, with close to 85% of
individuals reporting a reduction in severity as they enter adolescence and young adulthood.9,15 In a
longitudinal study by Bloch and colleagues,15 approximately 33% of participants were tic free by late
adolescence, and less than 25% showed mild or greater tic severity according to the Yale Global Tic
Severity Scale.16 Furthermore, studies have shown that more severe tics are positively correlated with
tic-related impairment in multiple settings.17,18 Unsurprisingly, tics greater in number, frequency,
intensity, complexity, and interference usually are more distressing and difficult to manage at home, in
school, and in other public places.19 Stiede and colleagues18 also demonstrated that motor tic
complexity and vocal tic number and intensity tend to contribute the most to impairment.
Although TD is defined by tics, co-occurring conditions are often present. Approximately 78% to 90% of
individuals with TD experience one or more comorbidities, with attention deficit-hyperactivity disorder
(ADHD) and obsessive-compulsive disorder (OCD) being the most common.2,14,20, 21, 22 Comorbid ADHD
is present in 30% to 50% of people with TD, and 10% to 50% have OCD.20,23 Children with TD are also at
a higher risk for anxiety disorders, oppositional defiant disorder, and mood disorders.2,20 Studies have
demonstrated that lower quality of life, lower self-esteem, and poorer social functioning are more
common for individuals with tics plus comorbidities than individuals with only tics.24, 25, 26

Variables affecting the expression of tics

It is not clear whether the development of tics can be prevented, but individuals with tics may be able
to use various strategies to prevent the worsening of tics and related psychosocial problems.
Numerous studies have examined the role behavior therapy can play in tic management. The
behavioral model suggests that settings (eg, school, home, friend’s house), activities (eg, sports,
music), the presence or absence of specific stimuli (eg, people, emotions, sensations), and reactions of
other people to tics (eg, parents, peers) can all directly influence the occurrence of tics.7 These
contextual variables can be broken down into antecedent and consequence factors.
Antecedents are external or internal events that occur before tics that may change the likelihood of tic
expression.7 Settings, activities, and other people are examples of external antecedents. Studies have
suggested that watching television and playing video games are associated with increases in tic
expression, whereas concentrating on artistic or creative activities, such as painting, taking
photographs, and playing/listening to music, are related to reductions in tics.27, 28, 29, 30 Internal
antecedents include feelings, such as stress, boredom, anger, and frustration. Himle and colleagues31
demonstrated that stressful situations worsened tics in 74% of children. Similarly, Silva and
colleagues30 showed that anxiety-producing situations, such as starting a new school year, waiting for
test results, and family conflict were the most common factors that increased tic severity.
Consequence variables are events that occur in reaction to tics. Studies suggest that reactions to tics
can maintain or strengthen future probability of tics via positive or negative reinforcement.7 For
example, Capriotti and colleagues32 demonstrated that social-based (eg, another kid teases child;
parent gives child a hug) and escape-based (eg, child allowed to stop doing homework) consequences
of tics were positively correlated with several dimensions of tic severity. Himle and colleagues31 also
showed that attention-based reactions to tics (eg, consoling, telling a child to stop ticcing) were related
to increases in tic frequency. Furthermore, Watson and Sterling33 examined the relationship between
parental attention and the prevalence of a 4-year-old child’s coughing tic. Results demonstrated that
parental attention for the tic was associated with greater tic severity, whereas positive parental
attention for the absence of the tic led to a decrease in tic expression. Combined, these studies suggest
that reactions to mild tics may further exacerbate them, and actively ignoring tics may prevent the
worsening of symptoms over time and lead to a less severe course.
Eaton and colleagues34 examined the relationship between internalizing symptoms, reactions to tics,
and tic severity. Results showed that children with higher levels of internalizing symptoms experienced
more reactions to tics. In particular, children’s total anxiety symptoms (ie, separation anxiety and social
anxiety) were significantly positively correlated with consequences they received for their tics and total
tic severity. Results also demonstrated that children with persistent tic disorders and increased
depression received more accommodations for and reactions to displaying tics. Finally, a regression
analysis indicated that total environmental consequences was a significant predictor of total tic
severity. Overall, these studies suggest that teaching families to shift attention to behaviors that
reduce tics instead of attending to tics is an important part of decreasing tic severity. Families that do
not learn this concept run the potential risk of creating an environment that could exacerbate tics. In
addition, with multiple studies demonstrating the influence of stress/anxiety on tics, the use of
relaxation techniques may be beneficial.

There is also some evidence that the ability of children with recent-onset tics to suppress their tics can
predict future tic severity. Kim and colleagues35 had 45 children with recent-onset tics complete
multiple tic suppression tasks in which they were asked to tic freely, to inhibit their tics, and to inhibit
their tics in the presence of a reward. Researchers examined the children’s tic severity at baseline and
at a 12-month follow-up. Results showed that participants who showed better tic suppression in the
presence of a reward exhibited reduced tic severity at the 12-month follow-up visit. These results
suggest that better tic-inhibitory ability at tic onset may be associated with longer-term remission
and/or reduction of tics, but future studies are needed to confirm this claim. Interestingly, simply
asking a child to inhibit tics in the absence of a reward did not predict future tic outcome; therefore,
the reward seems to be a key element in reducing the expression of tics.

Treatment options

Because ADHD and OCD are often more impairing than tics, and these comorbidities can influence the
effectiveness of behavioral treatment, such comorbid conditions should be managed before tic-specific
treatment begins.36,37 Furthermore, if children have provisional or mild tics, psychoeducation about tic
disorders and the impact of the environment on tics may be enough to alleviate concerns.38 However,
if tics are associated with impairment, such as distress in school, bullying, or physical pain, then
behavior therapy and pharmacotherapy are the 2 primary evidence-based interventions that should be
considered.
Recently, the American Academy of Neurology (AAN) published recommendations for the assessment
and treatment of tics, which were established by a multidisciplinary panel of tic experts.39 The panel
recommended that alpha-agonists should be considered in the treatment of tics, and that
antipsychotic medication may be considered when the benefits of treatment outweigh the risks.
Similarly, relative to other initial treatment options, such as other psychosocial/behavioral
interventions and medication, the most well-supported behavioral treatment, Comprehensive
Behavioral Intervention for Tics (CBIT), should be considered when treating tics.

Medication

Several medications serve as treatment options for tics. For milder tics, nonneuroleptic medications,
such as clonidine and guanfacine, are the recommended option. These alpha-2 adrenergic agonists are
regularly used to treat tics because they have relatively few side effects, but their effectiveness in
reducing tic severity is usually modest.40
For more severe tics, typical (eg, haloperidol, pimozide) and atypical neuroleptics (eg, aripiprazole,
risperidone) seem to be more effective than alpha-2 adrenergic agonists in reducing tic severity.41 The
efficacy of traditional neuroleptics (eg, haloperidol, pimozide, fluphenazine) has been demonstrated in
multiple placebo-controlled trials.42, 43, 44 In addition, studies suggested that pimozide may have fewer
side effects than haloperidol.45,46 Atypical neuroleptics, such as risperidone and aripiprazole have also
been shown to be more effective than placebo, equally effective to pimozide and clonidine, and helpful
for individuals with neuropsychiatric comorbidities.41 Unfortunately, side effects, such as dyskinesia,
acute dystonia, depression, weight gain, drowsiness, and cardiac concerns can occur.41 Although these
medications can reduce up to 70% of tics, side effects may restrict their use.47

Other Emerging Medical Therapies

Although not rated as having high empirical support in the AAN review, there are other emerging
medical therapies with some evidence for reducing tic severity. Recent studies have shown that
tetrabenazine and deutetrabenazine may improve tic severity.48, 49, 50 Furthermore, patients with
severe TD who have unsuccessfully tried medication and behavior therapy may benefit from deep
brain stimulation (DBS), a treatment in which a neurostimulator sends electrical impulses into areas
within the brain that have been associated with tics. Studies with adult patients have demonstrated
decreases in tic severity after DBS; however, research on DBS for children is minimal.51,52 Finally,
although there is some evidence that cannabinoids can significantly reduce tics, to date there is little
evidence that cannabis-based medication reduces tics in youth.53,54

Behavior Therapy

Behavioral treatment is considered the gold standard psychotherapy intervention for tic disorders,
with multiple randomized controlled trials demonstrating its efficacy and no side effects reported.36,38
Habit reversal training (HRT), a type of behavior therapy, has shown efficacy in multiple clinical trials
and meta-analyses.55, 56, 57, 58 Initially, it included 14 components, but Woods and colleagues59
suggested that awareness training, competing response training, and social support are the 3 main
therapeutic skills needed for the intervention. CBIT extended HRT to include psychoeducation and
functional assessment/interventions.
Currently, CBIT is the most well-supported nonpharmacological treatment for children with
tics.36,37,39,60 CBIT consists of psychoeducation, functional assessment/intervention, HRT, relaxation
training, and a motivational reward program.61 In CBIT, therapists first provide the client with
psychoeducation about tic disorders to minimize blame, stigma, and negative feelings related to the
client’s symptoms. Next, a functional assessment is completed to assess how the environment may
impact tic expression. The therapist and client discuss internal and external antecedents, such as
emotions, settings, and activities that are associated with increases in tic severity. For those
antecedents identified as being associated with tic exacerbation, therapists examine attention,
aversive, and escape-based consequences to tics that occur within these identified antecedents.
Following the functional assessment, functional interventions are developed to manage the
antecedents and consequences associated with worsening tic severity.61 Next, the clinician implements
HRT for each tic, which involves 3 elements. First, awareness training is completed to teach the client
to recognize each tic and its associated premonitory urge. This step is important because if clients are
not aware of their tics/urges, then it will be difficult to implement competing response exercises. After
clients are aware of approximately 80% of tic occurrence, competing response training begins.
Competing responses are behaviors that are physically incompatible with the target tic. Clients are
instructed to use the competing response contingent on the tic or premonitory urge for 1 minute or
until the urge goes away, whichever is longer. Finally, social support training is introduced to teach a
social support person, in most cases a parent, how to assist the child in the implementation of the
competing response. The support person’s job is to praise correct implementation of the competing
response and to prompt the children when they forget to do their competing response.61

Piacentini and colleagues62 demonstrated that CBIT is more effective than nonspecific supportive
therapy in reducing tics and tic-related impairment in children with tic disorders, with 53% of
participants showing significant improvement at the end of the 8-week intervention and 87% of
responders exhibiting continued benefit 6 months after treatment. Furthermore, Woods and
colleagues63 showed that CBIT does not lead to adverse effects on disruptive behavior, attention,
mood, and anxiety regulation, and Rizzo and colleagues64 suggested that behavior therapy is as
effective as neuroleptic medication in treating children and adolescents with tics.
Exposure and response prevention (ERP) for tics is another behavior therapy shown to reduce tics.65,66
In ERP, clients are asked to suppress their tics for gradually longer periods of time, with each 2-hour
session consisting of exposure to sensory experiences and response prevention of tics. Unlike CBIT, all
tics are targeted at once, and the therapist uses techniques, such as focusing on the urge, talking about
tics, and describing situations or activities related to increases in tics, to elicit the premonitory urge.
When tics occur, the therapist encourages the client to try even harder to suppress the tics, reminding
them of what they would gain if they ignore the urge to tic. In a randomized controlled trial (RCT),
Verdellen and colleagues66 found no differences in posttreatment tic severity scores between
participants given ERP or HRT. Pringsheim and colleagues39 noted that if CBIT is unavailable, ERP may
be an acceptable behavioral intervention.

Dissemination of behavior therapy

Although CBIT is effective at reducing tic severity and is rated as highly acceptable by clients,
accessibility remains a problem.67 A survey by Woods and colleagues68 demonstrated that most clients
desire CBIT, but only approximately 6% of treatment-seeking children/families and 4% of treatmentseeking adults have received CBIT. The most common reason given for not receiving CBIT was a lack of
knowledgeable and trained providers. Because CBIT’s limited availability, efforts have been made to
enhance its dissemination using telehealth and a self-guided Web-based treatment. Because there are
few providers trained in CBIT, these adaptations could provide greater access to the intervention.
To examine the effectiveness of CBIT delivered via telehealth, Himle and colleagues67 had 20 children
with TD complete 10 weeks of CBIT delivered either face-to-face or via videoconferencing. Regardless
of format, individuals demonstrated significant equivalent decreases in tic severity, which suggests that
receiving telehealth CBIT is a viable option for therapy. TicHelper.com (“TicHelper”) is another
treatment option if CBIT providers are inaccessible. TicHelper is an online, interactive self-help
program, based on CBIT, for individuals with tics from 8 years old to adolescence.69 The program was
developed using an iterative testing and feedback process involving CBIT professionals, children with
persistent tics, and their parents. An RCT comparing TicHelper with an Internet-based resources
condition has been completed but has not yet been published. However, the site is based on the
therapist manual used in Piacentini and colleagues,62 who showed that CBIT is more effective in
reducing tics and tic-related impairment in children than supportive therapy.
In another attempt to disseminate CBIT treatment, the Tourette Association of America (TA) offers the
TA-Behavior Therapy Institute, a 2-day in-person didactic and skills-based training for licensed social
workers, health, or mental health practitioners.70 After the training, each attendee can participate in 3
consultation calls with CBIT experts to discuss their training cases. An online training program, based

on the CBIT manual, is also being developed to provide therapists with another opportunity to become
trained in CBIT.

Predictors of treatment outcome

Few studies have examined moderators and predictors of response to behavior therapy for children
with tic disorders. Sukhodolsky and colleagues71 used data from 2 studies that compared CBIT with
psychoeducation and supportive therapy to investigate moderators and predictors of treatment
response. The combined sample consisted of 248 participants (177 male; 71 female), and selected
variables included presence of baseline tic medication, tic phenomenology, age, sex, family
functioning, treatment expectancy, and co-occurring ADHD, OCD, and anxiety disorders. Results
demonstrated that the treatment effect of CBIT was significantly larger for participants not on tic
medication compared with those on tic medication; yet, participants on tic medication still showed
improvements with CBIT. The remaining variables tested did not moderate outcome.
Furthermore, Sukhodolsky and colleagues71 suggested that co-occurring anxiety disorders, severity of
premonitory urges, participant positive expectancy, and higher overall severity, as measured by the
Clinical Global Impression – Severity (CGI-S), predicted tic severity outcomes regardless of treatment
assignment. For example, individuals with a comorbid anxiety disorder demonstrated less tic reduction
after 10 weeks of treatment. Similar results were found by Nissen and colleagues72 who showed that
high anxiety scores predicted less improvement in functional impairment after treatment. Thus,
although relaxation training is an element of the behavioral program, these findings suggest that
additional techniques to manage anxiety and stress may be beneficial for individuals with tics.
Premonitory urge severity was associated with lower tic reduction, suggesting that it may be more
difficult for children with stronger premonitory urges to manage tics.71 Furthermore, Sukhodolsky and
colleagues71 showed that optimism related to treatment outcome may be an important factor, as
parents’ and children’s positive expectancy for change was associated with greater tic reduction.
Similarly, Nissen and colleagues72 demonstrated that patients who believed that it is extremely difficult
to suppress tics, experienced poorer treatment outcome. Therefore, building rapport with clients to
increase optimism and beginning HRT with a tic in which there is a better chance for success may be
important elements for better treatment outcome. Both of these factors are emphasized in CBIT.
Finally, Sukhodolsky and colleagues71 showed that participants with higher initial tic severity
demonstrated greater tic reduction over time regardless of treatment condition.
Deckersbach and colleagues73 also examined predictors of treatment response. They used a
visuospatial priming task to investigate whether pretreatment response inhibition impairment in
individuals given HRT predicted reductions in tic severity. Results suggested that participants with
greater deficits in response inhibition did not respond as well to HRT, suggesting that it may be harder
for individuals with poor baseline response inhibition to use competing response exercises. Similarly,
other studies have found that attention problems are related to poorer tic suppressibility; thus,
problems with attention could predict poorer response to behavioral treatments.74,75

Summary

Although there is no information on how to prevent the development of tics, various strategies have
been shown to be effective in secondary and tertiary prevention of tics and related psychosocial
problems. A behavioral model indicates that contextual variables can impact tic expression; therefore,
functional assessments are used to identify antecedents and consequences related to tic exacerbation
and attenuation. Functional interventions also are used to modify antecedents and consequences
associated with greater tic severity. Furthermore, medication can be prescribed to reduce tic severity;
however, side effects may restrict their use. Finally, in CBIT, competing responses are implemented to
give individuals an exercise that they can use when they feel the urge to tic. Overall, although children
may be unable to prevent the development of tics, they can still use several strategies to reduce their
tic severity and impairment.
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